NASDAQ: GBT - Global Blood Therapeutics, Inc.

Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Global Blood Therapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и предоставлением методов лечения для недостаточно обслуживаемых сообществ пациентов. Он разрабатывает свой главный кандидат на продукт, таблетки Oxbryta (вокселотор), пероральный препарат для лечения серповидно-клеточной анемии (SCD), принимаемый один раз в день. Компания оценивает Oxbryta, которая завершила клинические испытания фазы III у взрослых и подростков с SCD.

mais detalhes
Он также оценивает безопасность и фармакокинетику однократных и многократных доз Oxbryta в клинических испытаниях фазы IIa на подростках и педиатрических пациентах с SCD. Компания имеет лицензию и соглашение о сотрудничестве с Syros Pharmaceuticals, Inc. для открытия, разработки и коммерциализации методов лечения ВСС и бета-талассемии. Global Blood Therapeutics, Inc. была основана в 2011 году со штаб-квартирой в Южном Сан-Франциско, Калифорния.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2015-08-12
ISIN US37890U1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.gbt.com
Цена ао 67.5
Alteração de preço por dia: 0% (68.49)
Alteração de preço por semana: 0% (68.49)
Alteração de preço por mês: 0% (68.49)
Alteração de preço em 3 meses: 0% (68.49)
Mudança de preço em seis meses: 0% (68.49)
Mudança de preço por ano: 0% (68.49)
Mudança de preço em 3 anos: +93.26% (35.44)
Mudança de preço em 5 anos: -3.48% (70.96)
Mudança de preço em 10 anos: 0% (68.49)
Mudança de preço desde o início do ano: 0% (68.49)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 18.8 1
P/BV 39.05 1
P/E 0 0
EV/EBITDA -1.38 0
Total: 3.63

Eficiência

Nome Significado Nota
ROA, % -35.64 0
ROE, % -204.89 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -2.28 10
Total: 7.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 11085.71 10
Rentabilidade Ebitda, % 61.93 8
Rentabilidade EPS, % 44.28 6
Total: 8.2
Mais detalhes

Instituições Volume Compartilhar, %
Perceptive Advisors LLC 8305378 13.31
Janus Capital Management LLC 5776388 8.96
BlackRock Fund Advisors 5215981 8.38
Fidelity Management & Research Company LLC 3431107 5.55
Fidelity Management & Research Company LLC 2613198 4.05
Franklin Advisers, Inc. 2468534 3.83
Fidelity SelectCo, LLC 1945980 3.02
Pharmakon Advisors L.P. 1904872 2.96
Logos Global Management LP 850000 1.38
Great Point Partners LLC 595473 0.96
Fidelity Investments 381839 0.62
Hartford Funds Management Company, LLC 370098 0.59
Arctis Global LLC 293700 0.47
BNP Paribas Asset Management Luxembourg 280239 0.45
Fairmount Funds Management LLC 210000 0.34
Fernwood Investment Management, LLC 208125 0.33
Fidelity Institutional Asset Management 194559 0.3
Botty Investors LLC 188508 0.3
Nuveen Fund Advisors, LLC. 182317 0.3
John Hancock Investment Management LLC 170815 0.27
Asymmetry Capital Management, L.P. 155232 0.25
Dsc Advisors LP 135000 0.22
SATTER MANAGEMENT CO., L.P. 126270 0.2
CT Mason 126249 0.2
Security Investors, LLC 86527 0.14
Asset Management One Co., Ltd. 72045 0.12
Driehaus Capital Management LLC 61330 0.1
Fidelity Investments Canada ULC 28582 0.04
Munder Lee Investments Ltd 20405 0.03
First Trust Portfolios L.P. 13336 0.02
First Midwest Bank 9887 0.02
Gesiuris Asset Management SGIIC 9000 0.01
AMG Funds LLC 8530 0.01
AQA Capital Limited 5000 0.01
Nicholas Investment Partners 1171 0
Hennion & Walsh, Inc 500 0
Hennion & Walsh, Inc 300 0

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
ProShares UltraShort Nasdaq Biotechnology 0.61 -40.36 1.76
Avantis Responsible International Equity ETF 0.0013 17.44 3.61591
Avantis International Equity ETF 0.00035 6.46 3.80856
Dimensional International Small Cap Value ETF 0.00003 7.13 4.55441
Dimensional International Small Cap ETF 0.00001 5.69 3.34747
Dimensional International Core Equity Market ETF 0 13.09 3.48343
Dimensional International Core Equity 2 ETF 0 6.52 3.69996
0.092.283.47



Supervisor Cargo Pagamento Ano de nascimento
Mr. Jeffrey S. Farrow CFO & Principal Accounting Officer 672.67k 1962 (63 ano)
Ms. Jung E. Choi Chief Bus. & Strategy Officer 645k 1970 (55 anos)
Mr. David L. Johnson Chief Commercial Officer 661.5k 1969 (56 anos)
Dr. David R. Phillips Founder & Advisor N/A
Ms. Nazila Habibizad Exec. VP of Operations N/A 1963 (62 ano)
Stephanie Yao Sr. Director of Corp. Communications & Investor Relations N/A
Dr. Matthew P. Jacobson Ph.D. Founder & Advisor N/A
Dr. Andrej Sali Ph.D. Founder & Advisor N/A
Dr. Ted W. Love M.D. Pres, CEO & Director 1.06M 1959 (66 anos)
Dr. Kim Smith-Whitley M.D. Exec. VP and Head of R&D 654k 1961 (64 ano)

Endereço: United States, South San Francisco, CA , 181 Oyster Point Boulevard - abrir no Google Maps, abrir mapas Yandex
Site: http://www.gbt.com